Trials / Recruiting
RecruitingNCT07172607
The Effect of Avnace eZZe on Sleep Improvement
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- TCI Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to examine the effectiveness of Avance eZZe drink with liposomal technology in improving sleep quality. Participants will be randomly assigned to either the placebo group, Avance eZZe drink group, and Avance eZZe drink without liposomal group, with 25 participants in each group. On the day of the experiment (day 0), participants are required to fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions. Subsequently, participants will be given the experimental samples and instructed to consume them 1 hour before sleep daily for 28 days. Follow-up assessments will be conducted in the day-1, day-14 and day-28, participants are required to fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Avance eZZe drink | 25 mL liquid sachet, 1 sachet/day, consume 1 sachet of the sample 1 hour before sleep daily |
| DIETARY_SUPPLEMENT | Avance eZZe drink (without liposomal) | 25 mL liquid sachet, 1 sachet/day, consume 1 sachet of the sample 1 hour before sleep daily |
| DIETARY_SUPPLEMENT | Placebo drink | 25 mL liquid sachet, 1 sachet/day, consume 1 sachet of the sample 1 hour before sleep daily |
Timeline
- Start date
- 2025-09-09
- Primary completion
- 2026-04-30
- Completion
- 2026-06-30
- First posted
- 2025-09-15
- Last updated
- 2026-02-04
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07172607. Inclusion in this directory is not an endorsement.